I

    InspireMD Inc (NSPR)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.89
    +0.04 (+4.80%)

    Market Cap: $39.81M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    85%(28/33)
    Avg Surprise
    +22.06%
    Streak
    5 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.15
    Range$-0.16 - $-0.15
    3 analysts
    EPS RevisionsNo revisions (7d)
    0
    1
    30d
    EPS Estimate Drift
    90d ago$-0.19-21.8%
    60d ago$-0.19-21.8%
    30d ago$-0.19-21.8%
    7d ago$-0.19-21.8%
    Current$-0.15
    Revenue Consensus
    $2M
    Range$2M - $2M
    3 analysts
    Dec 31, 2026
    EPS Consensus$0.08
    Range$-0.10 - $0.40
    3 analysts
    Revenue Consensus
    $4M
    Range$3M - $4M
    3 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.08---
    Sep 26EST
    		-$-0.15---
    Jun 26
    		$-0.17$-0.20+15.00%Beat+34.6%
    Mar 26
    		$-0.16$-0.18+11.11%Beat+27.3%
    Dec 25
    		$-0.14$-0.19+26.32%Beat+26.3%
    Sep 25
    		$-0.17$-0.19+10.53%Beat-6.3%
    Jun 25
    		$-0.26$-0.26+0.00%Beat-18.2%
    Mar 25
    		$-0.22$-0.20-10.00%Miss-4.8%
    Dec 24
    		$-0.19$-0.20+5.00%Beat-18.8%
    Sep 24
    		$-0.16$-0.20+20.00%Beat-6.7%
    Jun 24
    		$-0.22$-0.19-15.79%Miss+8.3%
    Mar 24
    		$-0.21$-0.15-40.00%Miss+60.4%
    Dec 23
    		$-0.16$-0.19+15.79%Beat+73.3%
    Sep 23
    		$-0.15$-0.15+0.00%Beat+74.1%
    Jun 23
    		$-0.24$-0.30+20.00%Beat+59.3%
    Mar 23
    		$-0.53$-0.68+22.06%Beat+7.0%
    Dec 22
    		$-0.60$-0.84+28.57%Beat-13.2%
    Sep 22
    		$-0.58$-0.73+20.55%Beat-9.4%
    Jun 22
    		$-0.59$-0.73+19.18%Beat-28.3%
    Mar 22
    		$-0.57$-0.80+28.75%Beat-7.5%
    Dec 21
    		$-0.53$-0.78+32.05%Beat+55.8%
    Sep 21
    		$-0.53$-0.82+35.37%Beat+41.1%
    Jun 21
    		$-0.46N/A+95.13%Beat+84.7%
    Mar 21
    		$-0.53$-0.60+11.67%Beat+91.8%
    Dec 20
    		$-1.20$-0.97-23.71%Miss+86.0%
    Sep 20
    		$-0.90N/A+66.67%Beat+95.2%
    Jun 20
    		$-3.00$-5.25+42.86%Beat+87.4%
    Mar 20
    		$-6.45$-9.45+31.75%Beat+88.7%
    Dec 19
    		$-8.55$-8.55+0.00%Beat-71.0%
    Sep 19
    		$-18.90$-20.25+6.67%Beat-656.0%
    Jun 19
    		$-23.85$-30.00+20.50%Beat-218.0%
    Mar 19
    		$-57.30$-37.50-52.80%Miss-5205.6%
    Dec 18
    		$-5.00N/AN/ABeat+32.2%
    Sep 18
    		$-2.50N/A+98.32%Beat+99.9%
    Jun 18
    		$-7.50N/A+94.96%Beat-3471.4%
    Mar 18
    		$-1.08N/AN/ABeat-66.2%
    Dec 17
    		$-7.38N/AN/ABeat+99.5%
    Sep 17
    		$-4987.50N/A+91.56%Beat-231.4%
    Jun 17
    		$-0.21N/AN/ABeat-
    Mar 17
    		$-0.65N/AN/ABeat-
    Dec 16
    		$-1531.72$0.00N/ABeat-
    Sep 16
    		$-1505.00$0.00N/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-1.39EV/EBITDA0.52x
    Price/FCF-1.54xFCF Yield-64.88%
    Profitability
    Profit Margin0.00%Operating Margin-816.00%
    ROE-202.80%ROIC-114.82%
    Financial Health
    Debt/Equity0.06xInterest CoverageN/A
    Current Ratio3.80xQuick Ratio3.52x
    Trading Statistics
    Beta0.77Avg Volume107.46K
    52-Week High$2.5752-Week Low$0.63

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.89
    SMA 20$0.85
    SMA 50$0.76
    SMA 200$1.34
    EMA 10$0.88
    EMA 20$0.85
    EMA 50$0.84
    EMA 200$1.30

    MACD

    Line: 0.04Signal: 0.04Hist: -0.00

    ADX

    ADX: 40.3+DI: 23.4-DI: 11.8

    Aroon & PSAR

    Aroon Up56.0
    Aroon Down20.0
    PSAR$1.00

    Bollinger Bands

    Upper Band$1.00
    Lower Band$0.70
    %B Position3458%(Upper)
    Band Width0.64

    RSI (14-Day)

    Neutral
    57.6

    Momentum Oscillators

    Stoch %K38.7
    Stoch %D49.0
    Williams %R-61.6
    ROC (10d)1.3%
    Momentum0.01
    CCI (20d)53.8
    MFI (14d)43.1

    Volatility Measures

    ATR (14d)$0.07(7.7%)
    StdDev (20d)0.07
    Hist Vol90.1%(High)

    Volume Flow

    VWAP$0.89
    OBV-14.9M
    AD Line-14.9M
    CMF (20d)0.187

    Volume Metrics

    Avg Vol (20d)110.9K
    Vol Ratio0.7x
    VWMA (20d)$0.88

    Pivot Points

    R3$0.95
    R2$0.92
    R1$0.89
    Pivot Point$0.86
    S1$0.82
    S2$0.79
    S3$0.76

    Advanced Oscillators

    TSI20.14
    Ultimate Osc51.2
    KST258.78

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.77M$3.40M$3.15M$2.52M$1.78M$1.53M$1.95M$1.81M$1.74M$1.51M$1.76M$1.56M
    Cost of Revenue$2.54M$2.71M$1.97M$1.66M$1.47M$1.24M$1.48M$1.40M$1.41M$1.22M$1.26M$1.12M
    Gross Profit$-774,000$687,000$1.18M$864,000$313,000$292,000$469,000$414,000$331,000$292,000$505,000$438,000
    Operating Expenses$13.67M$14.66M$13.26M$13.91M$13.33M$11.75M$9.84M$8.88M$8.59M$7.71M$6.31M$6.08M
    R&D$4.29M$4.76M$3.48M$3.63M$3.83M$4.06M$3.69M$3.92M$3.40M$2.63M$2.04M$2.11M
    SG&A$4.16M$4.72M$4.55M$5.89M$5.33M$4.94M$4.23M$3.49M$3.75M$3.84M$2.97M$3.09M
    Operating Income$-14,445,000$-13,978,000$-12,084,000$-13,051,000$-13,019,000$-11,460,000$-9,367,000$-8,462,000$-8,260,000$-7,414,000$-5,808,000$-5,639,000
    Interest Income$0$289,000$386,000$343,000$0$294,000$252,000$572,000$351,000$382,000$468,000$461,000
    Interest Expense$0$0$0$0$132,000$0$0$0$0$0$125,000$0
    Income Before Tax$-14,324,000$289,000$-11,698,000$-12,708,000$-13,151,000$-11,166,000$-9,115,000$-7,890,000$-7,909,000$-7,032,000$-5,340,000$-5,178,000
    Income Tax Expense$0$0$63,000$0$0$0$59,000$0$0$25,724$65,000$-58,000
    Net Income$-14,324,000$289,000$-11,761,000$-12,708,000$-13,151,000$-11,166,000$-9,174,000$-7,890,000$-7,909,000$-7,032,000$-5,405,000$-5,178,000
    EBITDA$-14,166,000$438,000$-11,555,000$-12,601,000$-12,912,000$-11,068,000$-9,040,000$-7,820,000$-7,843,000$-6,963,000$-5,279,000$-5,120,000
    EBIT$-14,324,000$289,000$-11,698,000$-12,708,000$-13,019,000$-11,166,000$-9,115,000$-7,890,000$-7,909,000$-7,032,000$-5,340,000$-5,178,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NSPR

    News

    Maxim Group Maintains InspireMD(NSPR.US) With Buy Rating, Maintains Target Price $3

    Maxim Group has reiterated its Buy rating for InspireMD (NSPR.US) and maintained its price target of $3. This indicates continued confidence from the firm in the company's stock performance.

    Moomoo•8/21/26•
    Bullish

    InspireMD (NSPR) Upgraded to Buy: Here's What You Should Know

    InspireMD (NSPR) has been upgraded to a Zacks Rank #2 (Buy) due to an upward trend in earnings estimates. This upgrade suggests an improvement in the company's underlying business and future earnings potential, which historically correlates with favorable stock price movement. The Zacks system identifies NSPR as a solid investment candidate, placing it in the top 20% of Zacks-covered stocks based on estimate revisions.

    Yahoo Finance•8/20/26•
    Bullish

    Maxim Group Maintains InspireMD(NSPR.US) With Buy Rating, Cuts Target Price to $3

    Maxim Group has reiterated its Buy rating for InspireMD (NSPR.US) but has adjusted its target price downwards to $3. This indicates a continued positive outlook on the company's stock, albeit with a revised valuation.

    Moomoo•8/20/26•
    Neutral

    InspireMD total revenue down 0.4% to USD 1,771,000 in Q2 2026

    InspireMD, Inc. reported a slight revenue decrease of 0.4% to $1,771,000 in Q2 2026 compared to the previous year, primarily due to a voluntary recall of a CGuard Prime delivery system which resulted in $734,000 in customer credits and a $612,000 inventory impairment. Despite a negative U.S. revenue, international revenue saw a 21% increase. The company is actively working with the FDA on regulatory submissions and design improvements for its CGuard products, anticipating re-entry into the U.S. market with both TCAR and CAS delivery systems later this year.

    Medical Buyer•8/18/26•
    Bearish

    InspireMD Releases Q2 2026 Financial Results

    InspireMD, Inc. (NSPR) reported its Q2 2026 financial results, with a narrower loss per share of -$0.17, beating analyst expectations by 15%, and revenue of $1.8M, surpassing estimates by 28%. Despite a slight revenue decrease year-over-year, international markets showed strong growth. Wall Street analysts maintain a bullish outlook on the stock.

    AlphaStreet•8/17/26•
    Bullish

    Frequently Asked Questions About NSPR

    Does NSPR pay dividends?
    InspireMD Inc (NSPR) does not currently pay a regular dividend.
    What is NSPR's market cap?
    InspireMD Inc (NSPR) has a market capitalization of $39.81M with a current stock price of $0.89.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In